Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomised, Double-blind, Placebo-controlled Trial

NCT05429580 is registered in ClinicalTrials.gov with Sanliurfa Mehmet Akif Inan Education and Research Hospital as lead sponsor.

NCT NCT05429580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05429580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomised, Double-blind, Placebo-controlled Trial
Lead sponsor
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2021
Completion date
February 28, 2022
Enrollment
480 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage, prophylactic tranexamic acid use, vaginal delivery